A life sciences company called ATAI just got a group of investors together to fund research and development into the therapeutic uses of psychedelics.
div > div.group > p:first-child"> Just weeks after the U.S. Food and Drug Administration approved approved Johnson & Johnson's ketamine-like nasal spray for depression, a group of European technology investors just got together for the largest-ever private financing round for a psychedelic medicine biotech company, ATAI.
ATAI is also the largest investor in a start-up called Compass Pathways, which is setting itself up to be the first legal provider of psilocybin. ATAI invested alongside Peter Thiel, the iconoclastic Silicon Valley investor and Facebook board member who's increasingly dabbling in health and biotech. ATAI co-founders Lars Wilde and Florian Brand previously worked with Compass; a third founder, Christian Angermayer, is a German entrepreneur and investor.
Adding further legitimacy to the space, Johnson & Johnson, the pharma giant, puts years of investment into studying into the benefits and potential side effects of esketamine. Its approval by the FDA represented the first new drug for depression in decades, although the medical establishment has stressed that more research is needed to better understand the long-term use of ketamine.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Lyft gets its first buy rating ahead of IPO that’s expected to price next weekLyft Inc. ‘s initial public offering will give investors their first chance to invest in a ride-sharing service that’s growing fast and capturing significant...
Weiterlesen »
Cisco has new strategy to invest in hot start-ups, as other venture capitalists flood the zoneCisco is unveiling Decibel, an early-stage venture firm run by Jon Sakoda, who spent 12 years at New Enterprise Associates.
Weiterlesen »
The star investor in 'The Big Short' is betting against Canadian banksSteve Eisman, the hedge fund manager famous for betting against the US housing market in 2008, is sounding the alarm on the Canadian market.
Weiterlesen »
Betting big on CBD: How to start a business few people understandAs CBD popularity explodes, new products are flooding the market. But with little regulation, how how can consumers know what’s actually good? For Nick Aragonesi, owner of the CBD Superstore in Queens, New York, that’s the problem he tackles every day.
Weiterlesen »
The breakthrough battery technology investors are betting millions onFor powering your smartphone or your Tesla, the lithium-ion battery is industry standard, and has been for nearly 30 years. Now, as the world races toward an electric future, the next big breakthrough in battery tech could be just around the corner.
Weiterlesen »
As worries about populism in Europe rise, investors bet on stock market volatilityInvestors are betting on heightened political uncertainty and greater volatility...
Weiterlesen »
Even the greediest capitalists are betting big on climate change. These are the trades they're making to profit from it.Even the most rapacious capitalists are betting big on climate change. These are the trades they're making to profit from it.
Weiterlesen »
All the celebrities and big names in attendance at Apple's big March event
Weiterlesen »